NCT06280040 2024-03-06
Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
Medical University of Vienna
Unknown
Clinical Trials
23 trialsNCT06284512 2024-02-29
Uveal Melanoma - Comparative Study
Medical University of Vienna
Unknown
NCT03068624 2024-01-25
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
M.D. Anderson Cancer Center
Phase 1 Unknown
NCT06073548 2023-10-10
SALOME Quali
Institut Curie
Unknown
NCT05889481 2023-06-18
MicroGenUM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Unknown
NCT03528408 2023-04-11
Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma
Hoosier Cancer Research Network
Phase 2 Unknown
NCT05077280 2022-12-06
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
California Pacific Medical Center Research Institute
Phase 2 Unknown
NCT05402059 2022-06-15
ISABELLA
MelanomaPRO, Russia
Unknown
NCT05179174 2022-01-05
The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
University of Catania
Unknown
NCT04025424 2021-12-28
ICIPRESIST19
Russian Academy of Medical Sciences
Unknown
NCT05047276 2021-09-17
PULSE-UM
Institut d'Investigació Biomèdica de Bellvitge
Phase 1/2 Unknown
NCT02913417 2021-04-19
Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
California Pacific Medical Center Research Institute
Phase 1/2 Unknown
NCT01925599 2021-03-26
BAP1 Testing in Instance Choroidal Nevi or Uveal Melanoma
Greater Houston Retina Research
Unknown
NCT02909517 2019-05-23
The Role of Inflammation in Ocular Tumours
Unity Health Toronto
Unknown
NCT02654821 2018-11-02
TCR
The Netherlands Cancer Institute
Phase 1/2 Unknown
NCT02379000 2017-02-08
TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy
Charite University, Berlin, Germany
Phase 4 Unknown
NCT01377025 2014-12-03
STREAM
University Hospital, Essen
Phase 2 Unknown
NCT00811200 2009-07-02
TORR
Leiden University Medical Center
Phase 2/3 Unknown
NCT00872391 2009-03-31
Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma
Medical University of Vienna
Phase NA Unknown
NCT00459849 2008-05-09
Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma
Barnes Retina Institute
Phase NA Unknown
NCT00540930 2007-10-08
Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy
Shields, Shields and Associates
Phase 4 Unknown
NCT00168870 2007-08-31
Study of Metastatic Ocular Melanoma
Charite University, Berlin, Germany
Phase 2 Unknown
NCT00406900 2006-12-06
Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma
Ludwig-Maximilians - University of Munich
Unknown